Immunopathogenesis of hepatitis C virus infection

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Volume 50, Issue 4, Pages (April 2009)
Vaccines for the elderly
R. Cavallo  Clinical Microbiology and Infection 
Breaking the Chain of Infection in Older Adults
Dr Paul T Francis, MD Community Medicine College of Medicine, Zawia
Muscle Cramps in Cirrhosis: A Moving Target
Leptin, obesity, and liver disease
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Hepatitis B and C virus-related carcinogenesis
Infectious causes of cancer: an evolving educational saga
Virological tools to diagnose and monitor hepatitis C virus infection
US Outbreak Investigations Highlight the Need for Safe Injection Practices and Basic Infection Control  Joseph F. Perz, DrPH, MA, Nicola D. Thompson,
NMD: Nonsense-Mediated Defense
Liver transplantation for hepatitis B virus-related liver disease: Indications, prevention of recurrence and results  Bruno Roche, Didier Samuel  Journal.
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16α-bromoepiandrosterone (HE2000)  C. Reading,
Jean-Michel Pawlotsky, MD, PhD  Clinics in Liver Disease 
Reservoir Host Immune Responses to Emerging Zoonotic Viruses
Individuals with inherited chromosomally integrated human herpes virus 6 (ciHHV-6) have functionally active HHV-6 specific T-cell immunity  V. Strenger,
Non-antibiotic strategies for sepsis
Fasiha Kanwal, MD, MSHS, Hashem B. El-Serag, MD, MPH 
B. Brett Finlay, Grant McFadden  Cell 
Pegylated interferons
Chronic HCV infection and the clonality of intrahepatic T cells
Jean-Michel Pawlotsky  Gastroenterology 
Hepatitis C: global epidemiology and strategies for control
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Vector control: a cornerstone in the malaria elimination campaign
Volume 68, Issue 3, Pages (March 2018)
Hepatitis C Virus Infection in the Older Patient
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response.
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Daniel J. Jackson, MD, James E. Gern, MD, Robert F. Lemanske, MD 
Elements of design: the knowledge on which we build
Infected aneurysm of the thoracic aorta
Hepatitis B and C virus-related carcinogenesis
Symposia and Oral Presentations
Volume 50, Issue 4, Pages (April 2009)
Pandemic lineages of extraintestinal pathogenic Escherichia coli
David Del Bello, Michael J. Ross, Shirish S. Huprikar 
Volume 148, Issue 3, Pages (March 2015)
Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection  E. Knops, E. Heger  Clinical Microbiology.
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
Antimicrobial drug development – the past, the present, and the future
Breaking the Chain of Infection in Older Adults
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Vaccines for the elderly
Dynamics of hepatitis B virus quasispecies heterogeneity in association with nucleos(t)ide analogue treatment determined by MALDI-TOF MS  M. Rybicka,
Volume 17, Issue 2, Pages (February 1950)
Statin use and clinical outcomes among pneumonia patients
An Update in the Management of Chronic Hepatitis B
Volume 51, Issue 2, Pages (August 2009)
Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij 
The atypical pneumonias: clinical diagnosis and importance
Tetsuo Takehara, Norio Hayashi 
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
Hepatitis C Genotypes: Current Trends and Future Implications
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Innate immune responses to infection
Endotoxin and the lung: Insight into the host-environment interaction
Vitamin D in allergic disease: Shedding light on a complex problem
The future of diagnostic bacteriology
Reversion of disease manifestations after HCV eradication
Infection and Malignancy in Rheumatic Diseases
Presentation transcript:

Immunopathogenesis of hepatitis C virus infection Kyong-Mi Chang, MD  Clinics in Liver Disease  Volume 7, Issue 1, Pages 89-105 (February 2003) DOI: 10.1016/S1089-3261(02)00068-5

Fig. 1 Components of the antiviral immune response. Upon viral infection, numerous host immune defense mechanisms are activated, starting with the innate response activated almost immediately in a nonspecific fashion, followed by the adaptive response targeting the specific pathogen. The outcome of infection is determined by the interplay between immune response and the virus. Clinics in Liver Disease 2003 7, 89-105DOI: (10.1016/S1089-3261(02)00068-5)